Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
FDA establishment 3003407523, Allendale, New Jersey, United States. Every inspection FDA has posted for the site, with its outcome and cited regulations.
Inspections: 4
Official action indicated: 0
Last inspection ended: Sep 29, 2025
Warning letters: 0
Inspections by Fiscal Year
FY2018 to FY2027 to date; 0 classified OAI
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
Biologics · Human Cellular, Tissue, and Gene Therapies
3 cited references
21 CFR 211.100(a). Absence of Written Procedures Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
21 CFR 314.80(b). Failure to develop written procedures Written procedures have not been developed for the receipt and evaluation of post marketing adverse drug experiences.
21 CFR 211.188(b)(2). Identity of major equipment and lines used Batch production and control records do not include the identity of individual major equipment used for each batch of drug product produced.
Voluntary Action Indicated (VAI)
Aug 26, 2019
Biologics · Human Cellular, Tissue, and Gene Therapies
None posted
No Action Indicated (NAI)
Apr 26, 2017
Biologics · Human Cellular, Tissue, and Gene Therapies
None posted
No Action Indicated (NAI)
Jun 17, 2014
Biologics · Human Cellular, Tissue, and Gene Therapies
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm.FDA Data Dashboard and warning letters